Zealand Pharma
ZEAL.CO
$93.17
Share price
-2.26%
Change (1 day)
125.86%
Change (1 year)
Categories
Zealand Pharma (ZEAL.CO) - P/B ratio
P/B ratio as of June 2024 : 14.4
According to Zealand Pharma's latest financial reports the company has a price-to-book ratio of 14.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Zealand Pharma - P/B ratio (from 2013 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 13.7 | 97.43% |
| 2022-12-31 | 6.93 | 573.44% |
| 2021-12-31 | 1.03 | -12.84% |
| 2020-12-31 | 1.18 | 10.94% |
| 2019-12-31 | 1.06 | 206.28% |
| 2018-12-31 | 0.3474 | -57.04% |
| 2017-12-31 | 0.8086 | -42.01% |
| 2016-12-31 | 1.39 | |
| 2015-12-31 | N/A | -100% |
| 2014-12-31 | 1.21 | 55.17% |
| 2013-12-31 | 0.7817 | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A |